398 related articles for article (PubMed ID: 15560462)
1. [Lymphadenitis in the left groin due to Bacillus Calmette-Guerin (BCG) vaccination].
Nieminen T; Salo E
Duodecim; 2004; 120(18):2247-50. PubMed ID: 15560462
[No Abstract] [Full Text] [Related]
2. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
Nazir Z; Qazi SH
J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
[TBL] [Abstract][Full Text] [Related]
3. Evaluating clinical course of BCG lymphadenitis and factors affect on it during a 5-year period in Kerman, Iran.
Daei Parizi M; Kardoust Parizi A; Izadipour S
J Trop Pediatr; 2014 Apr; 60(2):148-53. PubMed ID: 24327454
[TBL] [Abstract][Full Text] [Related]
4. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
Cerdá de Palou E; de Santy HP
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin lymphadenitis: a case report and review of the literature.
Victoria MS; Shah BR
Pediatr Infect Dis; 1985; 4(3):295-6. PubMed ID: 4000993
[No Abstract] [Full Text] [Related]
6. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
[TBL] [Abstract][Full Text] [Related]
7. Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain.
Kuchukhidze G; Kasradze A; Dolakidze T; Baliashvili D; Merabishvili T; Blumberg HM; Kempker RR
Emerg Infect Dis; 2015 Sep; 21(9):1677-9. PubMed ID: 26291303
[No Abstract] [Full Text] [Related]
8. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
[TBL] [Abstract][Full Text] [Related]
9. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren.
Dourado I; Rios MH; Pereira SM; Cunha SS; Ichihara MY; Goes JC; Rodrigues LC; Bierrenbach AL; Barreto ML
Int J Tuberc Lung Dis; 2003 Apr; 7(4):399-402. PubMed ID: 12729348
[TBL] [Abstract][Full Text] [Related]
10. The reporting and management of adverse reactions to bacillus Calmette-Guérin (BCG) vaccination.
Fitzgerald MJ; Duclos P
Can Dis Wkly Rep; 1991 May; 17(19):98-100. PubMed ID: 1860144
[No Abstract] [Full Text] [Related]
11. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
[TBL] [Abstract][Full Text] [Related]
12. [Adverse events following BCG vaccination].
Sagić L
Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
[TBL] [Abstract][Full Text] [Related]
13. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies.
Santos A; Dias A; Cordeiro A; Cordinhã C; Lemos S; Rocha G; Faria E
J Microbiol Immunol Infect; 2010 Dec; 43(6):530-7. PubMed ID: 21195982
[TBL] [Abstract][Full Text] [Related]
14. [The uses and effects of the Calmette-Guérin Mycobacterium bovis bacillus (BCG Vaccination)].
López-Antuñano FJ
Salud Publica Mex; 1997; 39(2):156-61. PubMed ID: 9254441
[No Abstract] [Full Text] [Related]
15. Treatment of Bacillus Calmette-Guérin-associated lymphadenitis.
Oğuz F; Müjgan S; Alper G; Alev F; Neyzi O
Pediatr Infect Dis J; 1992 Oct; 11(10):887-8. PubMed ID: 1408492
[No Abstract] [Full Text] [Related]
16. Is BCG vaccine innocent?
Karnak I; Senocak ME; Büyükpamukcu N; Göcmen A
Pediatr Surg Int; 1997 Feb; 12(2-3):220-3. PubMed ID: 9156871
[TBL] [Abstract][Full Text] [Related]
17. [Regional adenitis following BCG vaccination (author's transl)].
García Mérida M; Miguélez Lago C; Argos Rodríguez D; Bentabol Moreno G; López Pérez GA
An Esp Pediatr; 1979; 12(8-9):597-602. PubMed ID: 496095
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
Murphy D; Corner LA; Gormley E
Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of childhood pulmonary tuberculosis: a case control study in Nagpur, India.
Zodpey SP; Shrikhande SN; Maldhure BR; Vasudeo ND; Kulkarni SW
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):285-8. PubMed ID: 9886114
[TBL] [Abstract][Full Text] [Related]
20. Lupus vulgaris due to Mycobacterium bovis bacillus Calmette-Guérin (BCG) at the site of previous BCG vaccination.
Walker SL; Lozewicz S; Sood R; Mann TA; Campalani E; Hubbard VG
Clin Exp Dermatol; 2009 Oct; 34(7):e213-5. PubMed ID: 19120384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
